The FDA has approved Zycubo (copper histidinate) injection as the first and only treatment of Menkes disease in pediatric ...
The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens. Experts say the new injectable, which works ...
Weight loss medication Wegovy is now available in pill form, offering the same active ingredient as weekly injections.
Montréal, Canada - November 11, 2010 - Theratechnologies (TSX: TH) announced today that the U.S. Food and Drug Administration ("FDA") has approved EGRIFTATM (tesamorelin for injection) as the first ...
Giving fewer antibiotic injections to young infants in the developing world with severe infections such as pneumonia and sepsis is just as safe and effective as the standard course of twice daily ...
Researchers in China have found no statistically significant advantage for infrapatellar fat pad glucocorticoid injection ...
Marketing Approval Expands Treatment to Include Nearly 11 Million Patients Who Experience Opioid-Induced Constipation While Taking Opioids for Chronic Non-Cancer Pain RALEIGH, N.C. & TARRYTOWN, N.Y.-- ...
MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...
Weight-loss injections have transformed obesity treatment in recent years, but new research suggests the benefits may fade ...
Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback